1
Clinical Trials associated with LY-3478045A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Single-and Multiple Ascending Doses of LY3478045in Healthy Subjects
The main purpose of this study in healthy participants is to learn more about the safety of LY3478045 and any side effects that might be associated with it. The study will also measure how much LY3478045 gets into the bloodstream and how long it takes the body to get rid of it.
This study has two parts: Part A (one dose) will last about six weeks and Part B (more than one dose) will last about eight weeks for each participant.
100 Clinical Results associated with LY-3478045
100 Translational Medicine associated with LY-3478045
100 Patents (Medical) associated with LY-3478045
100 Deals associated with LY-3478045